NeuroMetrix, Inc. (NURO)
NASDAQ: NURO · Real-Time Price · USD
4.410
-0.011 (-0.25%)
Apr 1, 2025, 10:43 AM EDT - Market open

NeuroMetrix Market Cap

NeuroMetrix has a market cap or net worth of $9.01 million as of April 1, 2025. Its market cap has increased by 18.53% in one year.

Market Cap
9.01M
Enterprise Value
-5.66M
1-Year Change
18.53%
Ranking
Category
Stock Price
$4.41

Market Cap Chart

Since July 22, 2004, NeuroMetrix's market cap has decreased from $93.50M to $9.01M, a decrease of -90.37%. That is a compound annual growth rate of -10.69%.

History

DateMarket Cap% Change
Mar 31, 20259.10M12.35%
Dec 31, 20248.10M107.69%
Dec 29, 20233.90M-66.38%
Dec 30, 202211.60M-65.27%
Dec 31, 202133.40M178.33%
Dec 31, 202012.00M185.71%
Dec 31, 20194.20M-25.00%
Dec 31, 20185.60M36.59%
Dec 29, 20174.10M5.13%
Dec 30, 20163.90M-42.65%
Dec 31, 20156.80M-56.13%
Dec 31, 201415.50M78.16%
Dec 31, 20138.70M58.18%
Dec 31, 20125.50M12.24%
Dec 30, 20114.90M-68.79%
Dec 31, 201015.70M-72.31%
Dec 31, 200956.70M376.47%
Dec 31, 200811.90M-89.76%
Dec 31, 2007116.20M-38.29%
Dec 29, 2006188.30M-43.27%
Dec 30, 2005331.90M135.72%
Dec 31, 2004140.80M50.59%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 741.66B
UnitedHealth Group 479.08B
Johnson & Johnson 399.65B
AbbVie 370.64B
Novo Nordisk 302.16B
Abbott Laboratories 230.06B
Merck & Co. 226.74B
AstraZeneca 225.46B
Market Cap Rankings